Arjo AB (publ)
Research Arjo AB (publ) (ARJO-B) on Bullrun: valuation model: 11.3% undervalued, market cap SEK 7.59B, P/E 19.6, dividend yield 3.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerARJO-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Distribution
- CurrencySEK
- Valuation signal11.3% undervalued
- Market capSEK 7.59B
- P/E19.6
- Dividend yield3.4%
- Financial periodQ2 2026
- RevenueSEK 2.76B
- Net incomeSEK 125.00M
- Gross margin42.2%
Valuation Snapshot
Bullrun's latest valuation model marks Arjo AB (publ) as 11.3% undervalued; latest market cap is SEK 7.59B; P/E is 19.6; dividend yield is 3.4%.
Peer valuation comparison
Latest P/E is 19.63x versus a Healthcare sector median of 24.46x (19.7% below).
Latest dividend yield is 3.36% versus a Healthcare sector median of 2.11% (59.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 11.00B | SEK 334.00M | n/a | 42.6% | n/a | SEK 836.00M | SEK 5.35B | SEK 7.46B |
| FY2024 | SEK 11.29B | SEK 498.00M | SEK 1.12B | 43.5% | n/a | SEK 892.00M | SEK 5.42B | SEK 8.34B |
| FY2023 | SEK 10.98B | SEK 480.00M | SEK 1.66B | 43.1% | n/a | SEK 923.00M | n/a | SEK 7.58B |
| FY2022 | SEK 9.98B | SEK 449.00M | n/a | 41.9% | 1.64 | SEK 949.00M | n/a | SEK 7.43B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | SEK 7.59B | 19.6 | 3.4% | 0.95 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.95 SEK, yield 3.4%.
| Year | Dividends/share |
|---|---|
| FY2024 | 0.9 SEK |
| FY2023 | 0.85 SEK |
| FY2022 | 1.15 SEK |
About Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Arjo AB (publ) overvalued or undervalued?
Bullrun's valuation model currently marks Arjo AB (publ) as 11.3% undervalued.
What is Arjo AB (publ)'s market cap?
Arjo AB (publ)'s market capitalization is SEK 7.59B.
What is Arjo AB (publ)'s P/E ratio?
Arjo AB (publ)'s price-to-earnings (P/E) ratio is 19.6.
Does Arjo AB (publ) pay a dividend?
Arjo AB (publ) has a dividend yield of 3.4%.
What does Arjo AB (publ) do?
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics.